PATIENTS with moderate-to-severe atopic dermatitis showed generally low long-term upadacitinib safety event rates across ages. Upadacitinib Safety in Atopic Dermatitis Across Age ...

Can muscle stiffness predict stroke recovery? Read more about trunk control findings in acute stroke survivors.

PATIENTS with severe alopecia areata treated with upadacitinib achieved greater hair regrowth at Week 24 versus placebo. Upadacitinib in Severe Alopecia Areata. New subgroup data ...

A new prognostic score identifies key risk factors and predicts survival in CML blast phase, supporting improved risk stratification.

WHO recommends new tuberculosis testing tools, including near point-of-care tests and tongue swabs to improve diagnosis and access.

Breakthrough intranasal therapy for allergic rhinitis shows promise in targeting root causes. Learn how nanoparticles could change hayfever treatment.

Study finds indoor air pollution peaks in respiratory patients are driven by daily activities like cooking, often exceeding WHO guidelines.

Learn how synthetic radiographs challenge radiologists and AI, and discover their potential for training and research. Read more.

CONTINUOUS secukinumab treatment showed sustained hidradenitis suppurativa lesion control through 4 years in responding patients. Sustained Lesion Improvements with Secukinumab. N ...

Remibrutinib Shows Early CSU Symptom Relief. REMIBRUTINIB improved itch and hive severity within 12 hours in chronic spontaneous urticaria in Phase III analysis. A pooled analysis ...

Can smartphone data detect idiopathic pulmonary arterial hypertension earlier? New research suggests digital tools could transform screening. Read more.

Burnout is higher among sickle cell disease physicians, with reduced recreation and job pride identified as key contributing factors.